This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2022 Mar;603(7899):25-27.

doi: 10.1038/d41586-022-00562-0.

Hundreds of COVID trials could provide a deluge of new drugs

PMID: 35233098
DOI: 10.1038/d41586-022-00562-0

Hundreds of COVID trials could provide a deluge of new drugs

Heidi Ledford. Nature. 2022 Mar.

. 2022 Mar;603(7899):25-27.

doi: 10.1038/d41586-022-00562-0.

Author

PMID: 35233098
DOI: 10.1038/d41586-022-00562-0

No abstract available

Keywords: Drug discovery; SARS-CoV-2; Therapeutics.

PubMed Disclaimer

Similar articles

Why scientists are racing to develop more COVID antivirals.
Kozlov M. Kozlov M. Nature. 2022 Jan;601(7894):496. doi: 10.1038/d41586-022-00112-8. Nature. 2022. PMID: 35064230 No abstract available.
Treatment of COVID-19 in high-risk outpatients.
[No authors listed] [No authors listed] Med Lett Drugs Ther. 2022 Feb 7;64(1643):e1. Med Lett Drugs Ther. 2022. PMID: 35134051 No abstract available.
COVID-19 Therapeutics for Nonhospitalized Patients.
Gandhi RT, Malani PN, Del Rio C. Gandhi RT, et al. JAMA. 2022 Feb 15;327(7):617-618. doi: 10.1001/jama.2022.0335. JAMA. 2022. PMID: 35029659 No abstract available.
A comparative analysis of remdesivir and other repurposed antivirals against SARS-CoV-2.
Simonis A, Theobald SJ, Fätkenheuer G, Rybniker J, Malin JJ. Simonis A, et al. EMBO Mol Med. 2021 Jan 11;13(1):e13105. doi: 10.15252/emmm.202013105. Epub 2020 Nov 3. EMBO Mol Med. 2021. PMID: 33015938 Free PMC article. Review.
Treatment Options for Coronavirus Disease 2019 in Patients With Reduced or Absent Kidney Function.
Miller-Handley H, Luckett K, Govil A. Miller-Handley H, et al. Adv Chronic Kidney Dis. 2020 Sep;27(5):434-441. doi: 10.1053/j.ackd.2020.09.001. Epub 2020 Sep 17. Adv Chronic Kidney Dis. 2020. PMID: 33308510 Free PMC article. Review.

See all similar articles

Cited by

Interaction of copper potential metallodrugs with TMPRSS2: A comparative study of docking tools and its implications on COVID-19.
Vazquez-Rodriguez S, Ramírez-Contreras D, Noriega L, García-García A, Sánchez-Gaytán BL, Melendez FJ, Castro ME, de Azevedo WF Jr, González-Vergara E. Vazquez-Rodriguez S, et al. Front Chem. 2023 Jan 26;11:1128859. doi: 10.3389/fchem.2023.1128859. eCollection 2023. Front Chem. 2023. PMID: 36778030 Free PMC article.
Proxalutamide reduces SARS-CoV-2 infection and associated inflammatory response.
Qiao Y, Wotring JW, Zheng Y, Zhang CJ, Zhang Y, Jiang X, Pretto CD, Eyunni S, Parolia A, He T, Cheng C, Cao X, Wang R, Su F, Ellison SJ, Wang Y, Qin J, Yan H, Zhou Q, Ma L, Sexton JZ, Chinnaiyan AM. Qiao Y, et al. Proc Natl Acad Sci U S A. 2023 Jul 25;120(30):e2221809120. doi: 10.1073/pnas.2221809120. Epub 2023 Jul 17. Proc Natl Acad Sci U S A. 2023. PMID: 37459541 Free PMC article.
Recent advances in small-molecular therapeutics for COVID-19.
Zhong L, Zhao Z, Peng X, Zou J, Yang S. Zhong L, et al. Precis Clin Med. 2022 Sep 24;5(4):pbac024. doi: 10.1093/pcmedi/pbac024. eCollection 2022 Dec. Precis Clin Med. 2022. PMID: 36268466 Free PMC article. Review.
Deuterated Drugs and Biomarkers in the COVID-19 Pandemic.
Jansen-van Vuuren RD, Jedlovčnik L, Košmrlj J, Massey TE, Derdau V. Jansen-van Vuuren RD, et al. ACS Omega. 2022 Nov 13;7(46):41840-41858. doi: 10.1021/acsomega.2c04160. eCollection 2022 Nov 22. ACS Omega. 2022. PMID: 36440130 Free PMC article. Review.
Expert consensus on the diagnosis and treatment of severe and critical coronavirus disease 2019 (COVID-19).
Shang Y, Wu J, Liu J, Long Y, Xie J, Zhang D, Hu B, Zong Y, Liao X, Shang X, Ding R, Kang K, Liu J, Pan A, Xu Y, Wang C, Xu Q, Zhang X, Zhang J, Liu L, Zhang J, Yang Y, Yu K, Guan X, Chen D; Chinese Society of Critical Care Medicine, Chinese Medical Association. Shang Y, et al. J Intensive Med. 2022 Aug 26;2(4):199-222. doi: 10.1016/j.jointm.2022.07.001. eCollection 2022 Oct. J Intensive Med. 2022. PMID: 36785648 Free PMC article. No abstract available.

See all "Cited by" articles

References

1. RECOVERY Collaborative Group N. Engl. J. Med. 384, 693–704 (2021). - DOI
1. Zhou, S. et al. J. Infect Dis. 224, 415–419 (2021). - PubMed - DOI - PMC
1. White, K. M. et al. Science 371, 926–931 (2021). - PubMed - DOI - PMC
1. Arribas, J. R. et al. N. Engl. J. Med. Evid. https://doi.org/10.1056/EVIDoa2100044 (2021). - DOI

MeSH terms

Substances

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
Medical
- MedlinePlus Health Information
Miscellaneous
- NCI CPTAC Assay Portal